investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Markus Muschen

Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia

Trachea, bronchus and lung

Fred R Hirsch

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis

Trachea, bronchus and lung

Pathology

Ashish Lal

Regulation of microRNA expression by Mutant p53

Trachea, bronchus and lung

Javed Khan

Targeting FGFR4, RAS, and PAX3-FOXO1 Gene in Rhabdomyosarcoma

Trachea, bronchus and lung

Pediatric oncology or childhood cancer

David FitzGerald

Bio-Therapies for the Treatment of Cancer

Trachea, bronchus and lung

Pinar Ozden Eser

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Trachea, bronchus and lung

Peter Kent Jackson

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

Trachea, bronchus and lung

Yanxiang Guo

The role of autophagy in Kras-driven lung cancer

Trachea, bronchus and lung

Pathology

Crystal Mackall

Immunobiology and Immunotherapy of Pediatric Cancer

Trachea, bronchus and lung

Pediatric oncology or childhood cancer